TNF and rheumatoid arthritis: Pharmacological therapies for RA have evolved over the past 25 years, with biologic response modifier treatments such as tumor necrosis factor alpha (TNF-α) inhibitors becoming available in the late 1990s44 – after most of the studies in this review were carried out.